Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Glucagon-Like Peptide 1 in the Brain: Where Is It Coming From, Where Is It Going?

Daniels D, Mietlicki-Baase EG.

Diabetes. 2019 Jan;68(1):15-17. doi: 10.2337/dbi18-0045. No abstract available.

2.

The motivation to behaviorally thermoregulate during passive heat exposure in humans is dependent on the magnitude of increases in skin temperature.

Vargas NT, Slyer J, Chapman CL, Johnson BD, Temple JL, Mietlicki-Baase EG, Schlader ZJ.

Physiol Behav. 2018 Oct 1;194:545-551. doi: 10.1016/j.physbeh.2018.07.009. Epub 2018 Jul 11.

PMID:
30017641
3.

Glucagon-like peptide-1 receptor activation in the ventral tegmental area attenuates cocaine seeking in rats.

Hernandez NS, Ige KY, Mietlicki-Baase EG, Molina-Castro GC, Turner CA, Hayes MR, Schmidt HD.

Neuropsychopharmacology. 2018 Sep;43(10):2000-2008. doi: 10.1038/s41386-018-0010-3. Epub 2018 Feb 14.

4.

A vitamin B12 conjugate of exendin-4 improves glucose tolerance without associated nausea or hypophagia in rodents.

Mietlicki-Baase EG, Liberini CG, Workinger JL, Bonaccorso RL, Borner T, Reiner DJ, Koch-Laskowski K, McGrath LE, Lhamo R, Stein LM, De Jonghe BC, Holz GG, Roth CL, Doyle RP, Hayes MR.

Diabetes Obes Metab. 2018 May;20(5):1223-1234. doi: 10.1111/dom.13222. Epub 2018 Feb 20.

5.

Amylin in Alzheimer's disease: Pathological peptide or potential treatment?

Mietlicki-Baase EG.

Neuropharmacology. 2018 Jul 1;136(Pt B):287-297. doi: 10.1016/j.neuropharm.2017.12.016. Epub 2017 Dec 9. Review.

6.

Thioamide Substitution Selectively Modulates Proteolysis and Receptor Activity of Therapeutic Peptide Hormones.

Chen X, Mietlicki-Baase EG, Barrett TM, McGrath LE, Koch-Laskowski K, Ferrie JJ, Hayes MR, Petersson EJ.

J Am Chem Soc. 2017 Nov 22;139(46):16688-16695. doi: 10.1021/jacs.7b08417. Epub 2017 Nov 13.

PMID:
29130686
7.

Glucagon-Like Peptide-1 Receptor Signaling in the Lateral Dorsal Tegmental Nucleus Regulates Energy Balance.

Reiner DJ, Leon RM, McGrath LE, Koch-Laskowski K, Hahn JD, Kanoski SE, Mietlicki-Baase EG, Hayes MR.

Neuropsychopharmacology. 2018 Feb;43(3):627-637. doi: 10.1038/npp.2017.225. Epub 2017 Sep 18.

8.

Amylin receptor activation in the ventral tegmental area reduces motivated ingestive behavior.

Mietlicki-Baase EG, McGrath LE, Koch-Laskowski K, Krawczyk J, Reiner DJ, Pham T, Nguyen CTN, Turner CA, Olivos DR, Wimmer ME, Schmidt HD, Hayes MR.

Neuropharmacology. 2017 Sep 1;123:67-79. doi: 10.1016/j.neuropharm.2017.05.024. Epub 2017 May 25.

9.

Daily supplementation of dietary protein improves the metabolic effects of GLP-1-based pharmacotherapy in lean and obese rats.

Mietlicki-Baase EG, Koch-Laskowski K, McGrath LE, Krawczyk J, Pham T, Lhamo R, Reiner DJ, Hayes MR.

Physiol Behav. 2017 Aug 1;177:122-128. doi: 10.1016/j.physbeh.2017.04.017. Epub 2017 Apr 19.

PMID:
28433470
10.

Amylin Acts in the Lateral Dorsal Tegmental Nucleus to Regulate Energy Balance Through Gamma-Aminobutyric Acid Signaling.

Reiner DJ, Mietlicki-Baase EG, Olivos DR, McGrath LE, Zimmer DJ, Koch-Laskowski K, Krawczyk J, Turner CA, Noble EE, Hahn JD, Schmidt HD, Kanoski SE, Hayes MR.

Biol Psychiatry. 2017 Dec 1;82(11):828-838. doi: 10.1016/j.biopsych.2016.12.028. Epub 2017 Jan 10.

11.

Hindbrain DPP-IV inhibition improves glycemic control and promotes negative energy balance.

Mietlicki-Baase EG, McGrath LE, Koch-Laskowski K, Krawczyk J, Pham T, Lhamo R, Reiner DJ, Hayes MR.

Physiol Behav. 2017 May 1;173:9-14. doi: 10.1016/j.physbeh.2017.01.038. Epub 2017 Jan 22.

PMID:
28119159
12.

Binge-type eating disrupts dopaminergic and GABAergic signaling in the prefrontal cortex and ventral tegmental area.

Corwin RL, Wojnicki FH, Zimmer DJ, Babbs RK, McGrath LE, Olivos DR, Mietlicki-Baase EG, Hayes MR.

Obesity (Silver Spring). 2016 Oct;24(10):2118-25. doi: 10.1002/oby.21626. Epub 2016 Aug 25.

13.

Astrocytes Regulate GLP-1 Receptor-Mediated Effects on Energy Balance.

Reiner DJ, Mietlicki-Baase EG, McGrath LE, Zimmer DJ, Bence KK, Sousa GL, Konanur VR, Krawczyk J, Burk DH, Kanoski SE, Hermann GE, Rogers RC, Hayes MR.

J Neurosci. 2016 Mar 23;36(12):3531-40. doi: 10.1523/JNEUROSCI.3579-15.2016.

14.

Amylin-mediated control of glycemia, energy balance, and cognition.

Mietlicki-Baase EG.

Physiol Behav. 2016 Aug 1;162:130-40. doi: 10.1016/j.physbeh.2016.02.034. Epub 2016 Feb 27. Review.

15.

Glucagon-Like Peptide-1 Receptor Activation in the Ventral Tegmental Area Decreases the Reinforcing Efficacy of Cocaine.

Schmidt HD, Mietlicki-Baase EG, Ige KY, Maurer JJ, Reiner DJ, Zimmer DJ, Van Nest DS, Guercio LA, Wimmer ME, Olivos DR, De Jonghe BC, Hayes MR.

Neuropsychopharmacology. 2016 Jun;41(7):1917-28. doi: 10.1038/npp.2015.362. Epub 2015 Dec 17.

16.

Cooperative interaction between leptin and amylin signaling in the ventral tegmental area for the control of food intake.

Mietlicki-Baase EG, Olivos DR, Jeffrey BA, Hayes MR.

Am J Physiol Endocrinol Metab. 2015 Jun 15;308(12):E1116-22. doi: 10.1152/ajpendo.00087.2015. Epub 2015 Apr 21.

17.

Amylin modulates the mesolimbic dopamine system to control energy balance.

Mietlicki-Baase EG, Reiner DJ, Cone JJ, Olivos DR, McGrath LE, Zimmer DJ, Roitman MF, Hayes MR.

Neuropsychopharmacology. 2015 Jan;40(2):372-85. doi: 10.1038/npp.2014.180. Epub 2014 Jul 18.

18.

Glucagon-like peptide-1 receptor activation in the nucleus accumbens core suppresses feeding by increasing glutamatergic AMPA/kainate signaling.

Mietlicki-Baase EG, Ortinski PI, Reiner DJ, Sinon CG, McCutcheon JE, Pierce RC, Roitman MF, Hayes MR.

J Neurosci. 2014 May 14;34(20):6985-92. doi: 10.1523/JNEUROSCI.0115-14.2014.

19.

Incretins and amylin: neuroendocrine communication between the gut, pancreas, and brain in control of food intake and blood glucose.

Hayes MR, Mietlicki-Baase EG, Kanoski SE, De Jonghe BC.

Annu Rev Nutr. 2014;34:237-60. doi: 10.1146/annurev-nutr-071812-161201. Epub 2014 Apr 10.

20.

Amylin activates distributed CNS nuclei to control energy balance.

Mietlicki-Baase EG, Hayes MR.

Physiol Behav. 2014 Sep;136:39-46. doi: 10.1016/j.physbeh.2014.01.013. Epub 2014 Jan 28. Review.

21.

Intraduodenal milk protein concentrate augments the glycemic and food intake suppressive effects of DPP-IV inhibition.

Olivos DR, McGrath LE, Turner CA, Montaubin O, Mietlicki-Baase EG, Hayes MR.

Am J Physiol Regul Integr Comp Physiol. 2014 Feb 1;306(3):R157-63. doi: 10.1152/ajpregu.00358.2013. Epub 2013 Dec 18.

22.

The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA/kainate receptors.

Mietlicki-Baase EG, Ortinski PI, Rupprecht LE, Olivos DR, Alhadeff AL, Pierce RC, Hayes MR.

Am J Physiol Endocrinol Metab. 2013 Dec 1;305(11):E1367-74. doi: 10.1152/ajpendo.00413.2013. Epub 2013 Oct 8.

23.

Hindbrain GLP-1 receptor-mediated suppression of food intake requires a PI3K-dependent decrease in phosphorylation of membrane-bound Akt.

Rupprecht LE, Mietlicki-Baase EG, Zimmer DJ, McGrath LE, Olivos DR, Hayes MR.

Am J Physiol Endocrinol Metab. 2013 Sep 15;305(6):E751-9. doi: 10.1152/ajpendo.00367.2013. Epub 2013 Jul 30.

24.

Amylin receptor signaling in the ventral tegmental area is physiologically relevant for the control of food intake.

Mietlicki-Baase EG, Rupprecht LE, Olivos DR, Zimmer DJ, Alter MD, Pierce RC, Schmidt HD, Hayes MR.

Neuropsychopharmacology. 2013 Aug;38(9):1685-97. doi: 10.1038/npp.2013.66. Epub 2013 Mar 8.

Supplemental Content

Loading ...
Support Center